2024
Efficacy and Safety of Ketamine/Esketamine in Bipolar Depression in a Clinical Setting.
Santucci M, Ansari M, Nikayin S, Radhakrishnan R, Rhee T, Wilkinson S. Efficacy and Safety of Ketamine/Esketamine in Bipolar Depression in a Clinical Setting. The Journal Of Clinical Psychiatry 2024, 85 PMID: 39361411, DOI: 10.4088/jcp.24m15376.Peer-Reviewed Original ResearchConceptsBipolar depressionAcute seriesRisk of affective switchDiagnosis of bipolar depressionRefractory bipolar depressionAcute phaseMADRS scoreAffective switchIntranasal esketamineManic episodesBipolar disorderCohort of patientsAttending psychiatristsSource of morbidityEsketamineSample of patientsIV ketamineMaintenance treatmentDepressionClinical responseHeightened riskClinical outcomesMania/hypomaniaKetamineKetamine/esketamine
2023
Pharmacological and Somatic Treatment Effects on Suicide in Adults: A Systematic Review and Meta-Analysis
Wilkinson S, Diaz D, Rupp Z, Kidambi A, Ramirez K, Flores J, Avila‐Quintero V, Rhee T, Olfson M, Bloch M. Pharmacological and Somatic Treatment Effects on Suicide in Adults: A Systematic Review and Meta-Analysis. FOCUS The Journal Of Lifelong Learning In Psychiatry 2023, 21: 197-208. PMID: 37201149, PMCID: PMC10172559, DOI: 10.1176/appi.focus.23021006.Peer-Reviewed Original ResearchOdds of suicidePlacebo/Suicide riskPsychotic disordersBipolar disorderSuicide deathsMeta-analyzed associationsNon-clozapine antipsychoticsMagnetic seizure therapySomatic interventionsVagus nerve stimulationNewcastle-Ottawa ScaleAntiepileptic mood stabilizersTranscranial magnetic stimulationCertain clinical contextsDirect current stimulationEffects of pharmacologicPublic health crisisElectroconvulsive therapySeizure therapyNerve stimulationMood stabilizersStudy qualityProtective effectMagnetic stimulation
2018
Identifying Recipients of Electroconvulsive Therapy: Data From Privately Insured Americans
Wilkinson ST, Agbese E, Leslie DL, Rosenheck RA. Identifying Recipients of Electroconvulsive Therapy: Data From Privately Insured Americans. Psychiatric Services 2018, 69: 542-548. PMID: 29385954, PMCID: PMC6248332, DOI: 10.1176/appi.ps.201700364.Peer-Reviewed Original ResearchConceptsElectroconvulsive therapyMood disordersClinical characteristicsECT useUse of ECTCharacteristics of patientsProportion of patientsComorbid psychiatric disordersMajor depressive disorderNumber of prescriptionsSubstance use disordersOutpatient psychotherapy visitsECT patientsECT utilization rateMarketScan databasePsychotherapy visitsPsychotropic medicationsDepressive disorderPsychiatric disordersService useUse disordersPatientsECT utilizationBipolar disorderCommercial insurance